Saint Bernice, IN, United States of America

John Eric Hart

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2003.


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of John Eric Hart

Introduction

John Eric Hart is a notable inventor based in Saint Bernice, Indiana. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds. His work has led to advancements in pharmaceutical applications, showcasing his expertise and innovative spirit.

Latest Patents

John Eric Hart holds a patent for the "Enantioselective acylation of cis racemic azetidinones." This patent describes cis-β-lactam compounds that are prepared through the enantioselective acylation of the free amine in the presence of Penicillin G Amidase. His innovative approach has the potential to enhance the efficacy of various pharmaceutical products.

Career Highlights

Hart is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role at Eli Lilly allows him to work on cutting-edge research and development projects that aim to improve healthcare outcomes. With a focus on innovation, he continues to contribute to the advancement of medical science.

Collaborations

Throughout his career, John Eric Hart has collaborated with talented individuals such as Kathy Sue Crichfield and Radhe Krishan Vaid. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions.

Conclusion

John Eric Hart's contributions to the field of chemistry and his innovative patent demonstrate his commitment to advancing pharmaceutical science. His work at Eli Lilly and Company, along with his collaborations, highlights the importance of teamwork in driving innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…